1. Home
  2. LEXX vs FOSL Comparison

LEXX vs FOSL Comparison

Compare LEXX & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • FOSL
  • Stock Information
  • Founded
  • LEXX 2004
  • FOSL 1984
  • Country
  • LEXX Canada
  • FOSL United States
  • Employees
  • LEXX 7
  • FOSL N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • FOSL Consumer Specialties
  • Sector
  • LEXX Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • LEXX 38.9M
  • FOSL 112.2M
  • IPO Year
  • LEXX N/A
  • FOSL 1993
  • Fundamental
  • Price
  • LEXX $2.23
  • FOSL $1.85
  • Analyst Decision
  • LEXX Strong Buy
  • FOSL
  • Analyst Count
  • LEXX 2
  • FOSL 0
  • Target Price
  • LEXX $11.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • LEXX 202.4K
  • FOSL 2.2M
  • Earning Date
  • LEXX 01-10-2025
  • FOSL 11-07-2024
  • Dividend Yield
  • LEXX N/A
  • FOSL N/A
  • EPS Growth
  • LEXX N/A
  • FOSL N/A
  • EPS
  • LEXX N/A
  • FOSL N/A
  • Revenue
  • LEXX $464,278.00
  • FOSL $1,223,954,000.00
  • Revenue This Year
  • LEXX $20.39
  • FOSL N/A
  • Revenue Next Year
  • LEXX $113.25
  • FOSL N/A
  • P/E Ratio
  • LEXX N/A
  • FOSL N/A
  • Revenue Growth
  • LEXX 105.24
  • FOSL N/A
  • 52 Week Low
  • LEXX $1.20
  • FOSL $0.75
  • 52 Week High
  • LEXX $6.85
  • FOSL $2.61
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.23
  • FOSL 55.78
  • Support Level
  • LEXX $2.00
  • FOSL $1.64
  • Resistance Level
  • LEXX $2.54
  • FOSL $2.01
  • Average True Range (ATR)
  • LEXX 0.24
  • FOSL 0.19
  • MACD
  • LEXX -0.00
  • FOSL -0.03
  • Stochastic Oscillator
  • LEXX 27.06
  • FOSL 31.82

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: